GMED earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E 17.36. Updated 2026-07-23.
Globus Medical (GMED) Research Hub
Globus Medical (GMED) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 81.83 USD (+0.52%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 17.36, market cap 10.17B. This hub links to the full technical, earnings and options research available for GMED.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, US |
| Last close | 81.83 USD (+0.52%) |
| 52-week range | 72.54 USD – 88.89 USD |
| Trend regime | Range |
| 14-day RSI | 64.2 (Bullish) |
| Trailing P/E | 17.36 |
| Market cap | 10.17B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for GMED
Covered Call on GMED: how it works, illustrative setup around the real 81.83 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GMED: how it works, illustrative setup around the real 81.83 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GMED: how it works, illustrative setup around the real 81.83 USD price, max profit/loss, breakeven and when to use it. Educational.
GMED technical analysis: range, last 81.83 USD, RSI 64.2, 52w range 72.54 USD–88.89 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is GMED in?
Globus Medical (GMED) is classified under Healthcare (Medical - Devices), listed on NYSE, US.
Is GMED in an uptrend or downtrend?
As of 2026-10-26, GMED is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GMED's trailing P/E ratio?
GMED's trailing P/E is 17.36, with a market cap of 10.17B. See the earnings research page for full valuation detail.
When does GMED next report earnings?
GMED is next scheduled to report earnings on 2026-08-06.